Infinium Pharmachem Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Infinium Pharmachem Ltd is ₹ 208 as of 06 May 15:30 . The P/E Ratio of Infinium Pharmachem Ltd changed from 28.2 on March 2024 to 46.3 on March 2025 . This represents a CAGR of 28.13% over 2 yearsThe P/E Ratio of Procter & Gamble Health Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Infinium Pharmachem Ltd changed from ₹ 318.68 crore on March 2024 to ₹ 376.96 crore on March 2025 . This represents a CAGR of 8.76% over 2 yearsThe Market Cap of Procter & Gamble Health Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Infinium Pharmachem Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Procter & Gamble Health Ltd for the Sep '25 is ₹ 329.87 crore as compare to the Jun '25 revenue of ₹ 342.77 crore. This represent the decline of -3.76% The ebitda of Infinium Pharmachem Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Procter & Gamble Health Ltd for the Sep '25 is ₹ 125.22 crore as compare to the Jun '25 ebitda of ₹ 94.37 crore. This represent the growth of 32.69% The net profit of Infinium Pharmachem Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 88.54 crore over 6 quarters. This represents a CAGR of 53.49% The dividend payout of Infinium Pharmachem Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Infinium Pharmachem Ltd

Infinium Pharmachem Limited was originally incorporated as 'Infinium Pharmachem Private Limited' on November 21, 2003 issued by the Registrar of Companies, Gujarat.
Later on, Company converted its status into Public Company and the name of Company was changed to 'Infinium Pharmachem Limited' vide fresh Certificate of Incorporation dated August 12, 2022.
Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates.
The Company has its manufacturing plant at Dist.
Anand, Gujarat, since inception. The Company's manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Infinium Pharmachem Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Infinium Pharmachem Ltd or Procter & Gamble Health Ltd?

Market cap of Infinium Pharmachem Ltd is 324 Cr while Market cap of Procter & Gamble Health Ltd is 8,854 Cr

What are the key factors driving the stock performance of Infinium Pharmachem Ltd and Procter & Gamble Health Ltd?

The stock performance of Infinium Pharmachem Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Infinium Pharmachem Ltd and Procter & Gamble Health Ltd?

As of May 6, 2026, the Infinium Pharmachem Ltd stock price is INR ₹208.0. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5334.05.

How do dividend payouts of Infinium Pharmachem Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Infinium Pharmachem Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.